IDO2 and renal cell carcinoma: Similarly, decreased tryptophan levels have also been reported, but downstream metabolites such as kynurenine, quinolinate, and the level of indoleamine 2,3-dioxygenase (IDO) (a tryptophan catalyst enzyme) were all increased in RCC [22].